Optometrists in Flushing, MI Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Flushing Optical Optometrist Medicare: Medicare Enrolled Practice Location: 105 S Cherry St, Flushing, MI 48433 Phone: 810-659-9181 Fax: 810-659-6811 |
Flushing Vision Clinic Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1379 Flushing Rd, Flushing, MI 48433 Phone: 810-659-3135 Fax: 810-659-0024 |
 Howard Foote, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1379 Flushing Rd, Flushing, MI 48433 Phone: 810-659-3135 |
Flushing Optical Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 105 S. Cherry Street, Flushing, MI 48433 Phone: 810-659-9181 Fax: 810-659-6811 |
Dr. Michael Wallace, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Flushing Rd, Flushing, MI 48433 Phone: 810-659-3135 Fax: 810-659-0024 |
 Breanna Renee Marshall, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Flushing Rd, Flushing, MI 48433 Phone: 810-659-3135 Fax: 810-659-0024 |
News Archive
Tooth scaling reduces CV disease risk
Taiwanese study results show that undergoing tooth scaling significantly reduces the risk for future myocardial infarction, stroke, and total cardiovascular events.
How alcohol impacts heart and stroke risk may differ for men and women
The volume of alcohol consumption may have a significantly different effect on heart and stroke risk in men and women, according to a study of Japanese people published in Stroke: Journal of the American Heart Association.
Unhealthy gut microbes play role in development of high blood pressure in rats
Researchers have found that the microorganisms residing in the intestines (microbiota) play a role in the development of high blood pressure in rats. The study is published in Physiological Genomics. It was chosen as an APSselect article for February.
Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.
› Verified 4 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Speech-Language Pathologists